Heart Failure

A new systematic review and meta-analysis is shedding light on the potential impact of inadequate health literacy on mortality and hospitalizations in heart failure patients.

New research suggests combining agents from the 3 classes could pay major dividends in terms of event-free and overall survival.

Individuals with obstructive sleep apnea were more frequently male, obese, and had more coronary heart disease when compared to those without OSA.

A new research letter has found declines in rural areas have not been as pronounced as declines in metropolitan areas.

New research suggests a group of 6 cancer biomarkers was associated with all-cause mortality and HF hospitalizations.

After receiving approval for a similar indication in type 2 diabetics in late 2019, the FDA has approved dapagliflozin for reducing risk of CV death and hospitalization in patients with HFrEF.

The latest scientific statement from the AHA addresses cardiovascular considerations before, during, and after pregnancy.